Eligibility Requirements Flashcards

A pharmacist holds a PharmD degree from a university in Lebanon and has been actively licensed and practicing pharmacy in France for nine years. She now wishes to apply for PEBC eligibility to practice in Canada. Which statement best describes her required pathway?

Answer: She must complete PEBC's credential assessment as an International Pharmacy Graduate (IPG) and, if required, write the Evaluating Examination before proceeding to the Qualifying Examination

PEBC determines eligibility pathways based on where and how pharmacy education was obtained — not where an applicant subsequently became licensed. A degree from Lebanon means she is classified as an International Pharmacy Graduate (IPG). Active licensure in France does not grant exemption from the Evaluating Examination. No Canada–France bilateral pharmacy recognition agreement exists that would allow automatic equivalency. She must proceed through the full PEBC IPG pathway.

Which of the following conditions would render an applicant INELIGIBLE to submit a registration for the PEBC Evaluating Examination at the time of application?

Answer: The applicant's English language proficiency test results are more than two years old at the time the application package is submitted to PEBC

PEBC requires that language proficiency test results (e.g., IELTS Academic, CELBAN, TEF Canada) be valid — meaning they must not have exceeded their two-year validity window — at the time the complete application is submitted. Submitting expired language scores makes the application incomplete and ineligible for processing. The length of the pharmacy program, absence of a home-country license, or a gap in practice history do not automatically disqualify an applicant from registering for the EE.

A pharmacist who graduated from an ACPE-accredited PharmD program in the United States is applying to PEBC. Which of the following statements about her eligibility for the Qualifying Examination is accurate?

Answer: She qualifies to proceed directly to the Qualifying Examination without first completing the Evaluating Examination, provided her degree is from an ACPE-accredited US institution

PEBC recognizes graduates of ACPE-accredited programs in the United States as equivalent to Canadian pharmacy graduates for the purpose of Qualifying Examination eligibility. They may proceed directly to QE Part I without writing the Evaluating Examination. This is a specific and important exception to the standard IPG pathway. She is not exempt from both parts of the QE, and PEBC — not WES — conducts credential assessment.

An IPG candidate passed the PEBC Evaluating Examination and subsequently passed Qualifying Examination Part I. Before she can schedule Part II (the OSCE), she discovers her Evaluating Examination results have passed their validity period. What is the most accurate description of her situation under PEBC policy?

Answer: She must rewrite the Evaluating Examination; however, her QE Part I result remains valid and she does not need to retake it

Under PEBC policy, the validity window applies to individual examination results independently. If EE results expire, the candidate must rewrite the Evaluating Examination to reestablish eligibility to continue through the QE process. However, a passed QE Part I result is not automatically voided simply because the EE result expired after the fact — the candidate does not need to repeat Part I. One-time administrative extensions are not a standard PEBC offering.

A candidate fails the PEBC Qualifying Examination Part II (OSCE) for the third consecutive time. Under PEBC policy, what must occur before any additional attempt at Part II is permitted?

Answer: The candidate must appear before a PEBC Assessment Panel, which evaluates their case and determines conditions — if any — under which further attempts may be made

After three unsuccessful attempts at Qualifying Examination Part II, PEBC does not grant automatic re-registration. The candidate must appear before a PEBC Assessment Panel. The panel reviews the candidate's examination history and circumstances, then determines whether further attempts will be permitted and under what conditions — if any. This is not a permanent ban, nor does it require retaking Part I automatically, and PEBC does not prescribe a mandatory supervised placement as the sole remedy.

During PEBC's credential verification process for an IPG applicant, PEBC discovers that the applicant did not disclose a formal disciplinary caution issued by a pharmacy regulatory body in their home country — even though the applicant indicated 'none' on the relevant declaration. The caution itself was minor and had been resolved. Which outcome is most consistent with PEBC's approach to such situations?

Answer: The non-disclosure itself is treated as a more serious integrity concern than the original caution, and the matter is escalated for further review regardless of the caution's severity

PEBC places substantial weight on candour and honesty throughout the application process. When an applicant fails to disclose a professional conduct finding — even a resolved, minor one — the act of non-disclosure is treated as an independent and serious integrity concern. The severity or resolution of the original caution does not mitigate the significance of the omission. Such cases are escalated for additional review, and the non-disclosure itself can jeopardize eligibility. Applicants are expected to disclose all findings and let PEBC assess their significance.